Trueblue, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Charles Schwab Investment Management Inc. has reported a change in its beneficial ownership of TrueBlue, Inc. common stock, now holding 3.94%.
NYSE
Boston Partners has disclosed beneficial ownership of 2,470,948 shares, representing 8.13% of TrueBlue, Inc.'s common stock as of June 30, 2026.
NYSE
Royce & Associates LP has filed a Schedule 13G, reporting beneficial ownership of 9.18% of TrueBlue, Inc. common stock as of June 30, 2026.
NYSE
Investment adviser Boston Partners has reported a 10.83% beneficial ownership stake in TrueBlue, Inc. as of March 31, 2026.
NYSE
Invesco Ltd. has filed a Schedule 13G disclosing a 0.2% beneficial ownership stake in TrueBlue Inc. as of March 31, 2026.
NYSE
Pzena Investment Management LLC has increased its beneficial ownership of TrueBlue, Inc. common stock to 10.5%, holding over 3.17 million shares.
NYSE
Royce & Associates LP has filed a Schedule 13G, reporting beneficial ownership of 7.03% of TrueBlue, Inc. common stock as of March 31, 2026.
NYSE
SCHEDULE: Boston Partners Discloses TrueBlue Stake
Boston Partners has filed a Schedule 13G, reporting beneficial ownership of 10.83% of TrueBlue, Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group has reported a 0% beneficial ownership in TrueBlue Inc. following an internal realignment that disaggregated its reporting.
NYSE
Charles Schwab Investment Management Inc. reported a 6.72% beneficial ownership stake in TrueBlue, Inc. common stock.
NYSE
Royce & Associates LP has filed an amended Schedule 13G, reporting a 5.47% beneficial ownership of TrueBlue, Inc.'s common stock as of December 31, 2025.
NYSE
Boston Partners, an investment adviser, reported a 7.41% beneficial ownership stake in TrueBlue, Inc. common stock as of December 31, 2025.
NYSE
Charles Schwab Investment Management Inc. has reported a 5.07% passive ownership stake in TrueBlue, Inc. common stock.
NYSE
Boston Partners, an investment adviser, has reported a 5.39% beneficial ownership stake in TrueBlue Inc., holding 1,611,515 shares of common stock.
NYSE
The Vanguard Group has reported an increased beneficial ownership in TrueBlue Inc., now holding 5.45% of the common stock.
NYSE
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G, reporting a de minimis beneficial ownership of 420 shares, representing 0.0% of TrueBlue Inc.'s common stock as of June 30, 2025.
NYSE
Royce & Associates LP has filed an amended Schedule 13G, revealing a 7.90% beneficial ownership stake in TrueBlue, Inc.'s common stock as of June 30, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a 7.1% beneficial ownership stake in TrueBlue Inc.'s common stock as of June 30, 2025.
NYSE
Royce & Associates LP, an investment adviser, has filed an amended Schedule 13G disclosing a passive beneficial ownership of 6.33% of TrueBlue, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: Dimensional Fund Advisors LP Updates Stake in TrueBlue Inc, Reports 4.8% Beneficial Ownership
Dimensional Fund Advisors LP has filed an Amendment No. 8 to Schedule 13G, disclosing a 4.8% beneficial ownership stake in TrueBlue Inc. as of March 31, 2025.
NYSE
Azarias Capital Management, L.P. has filed an amended Schedule 13G, disclosing that its beneficial ownership in TrueBlue, Inc. has decreased to 3.6% as of March 31, 2025, falling below the 5% reporting threshold.
NYSE
SCHEDULE 13G/A: Azarias Capital Management Amends TrueBlue Stake Disclosure, Correcting Beneficial Ownership to 5.8%
Azarias Capital Management, L.P. has filed an amended Schedule 13G, correcting its beneficial ownership in TrueBlue, Inc. to 1,721,785 shares, representing 5.8% of the common stock as of September 30, 2024.
NYSE
Royce & Associates LP, an investment adviser, has reported a 5.15% beneficial ownership stake in TrueBlue, Inc. common stock as of December 31, 2024.